News

2018 Mid-Year Update from WGND

As the global TB drug development community pushes forward to find new drug candidates and develop novel regimens to combat the TB epidemic, we'd like to highlight some updates in the field, WGND activities, and upcoming events in 2018. 

Upcoming Events in 2018: 

  • UN General Assembly holding high-level meeting on TB to take place 26 September 2018
  • 2018 WGND Annual Meeting is being planned to occur the week of October 23rd in The Hague, Netherlands. Further details will be disseminated soon.
More News
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...
5 Jun 2019
**Update: The US FDA Antimicrobial Drug Advisory Committee voted in favor of the NDA 14 to 4 on June 6th, 2019** The United States Food & Drug Administration (FDA) will host the Antimicrobial Drug Advisory Committee on Thursday, June 6th to discuss the new drug application (NDA) involving new...